NL-OMON47545已完成不适用
Safety and pharmacokinetics of antipsychotics in children with autism - SPACe
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •- Age 6 to 18 years
- •- Documented clinical diagnosis of autism spectrum disorder according to DSM IV or DSM V and comorbid behavioural problems
- •-Treated with either aripiprazole, risperidone or pipamperone
排除标准
- •- Diabetes type I or II
- •- Congenital or acquired syndrome associated with changes in appetite, body weight or lipid profile (e.g. Prader Willi)
- •- Treatment with another antipsychotic within the last 6 months
- •- Known Long QT syndrome (LQTS)
研究者
相似试验
招募中
不适用
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCTAutism Spectrum DisorderNL-OMON23089Erasmus Medical Center Rotterdam140
已完成
不适用
Safety and pharmacokinetics of antipsychotics in children with autismAutism Spectrum Disorder (autisme spectrum stoornis)NL-OMON22814Erasmus Medical Center Rotterdam90
进行中（未招募）
1 期
Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCTAutism spectrum disorderCTIS2024-511568-96-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)280
尚未招募
3 期
Effect of different antipsychotic medications on craving and craving related brain activity in patients with schizophrenia and cannabis abuse or dependence: a randomized controlled study comparing clozapine and risperidoneverslavingpsychotic disorders10039628schizophreniaNL-OMON32193Academisch Medisch Centrum70
尚未招募
不适用
To study and compare the side effects of one drug vs more than one drug in the treatment for schizophrenia.CTRI/2022/12/048297Department of psychiatry